CONCORDBIO.BOCONCORDBIO.BOBSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR-41.5%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
-41.5%/yr
Quarterly compound
Percentile
P64
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202514.46%
Q3 2025-23.40%
Q2 2025-52.25%
Q1 202546.60%
Q4 2024-34.69%
Q3 202447.38%
Q2 2024157.70%
Q1 2024-67.67%
Q4 2023-9.08%
Q3 202342.11%
Q2 2023-11.49%
Q1 2023-12.92%
Q4 202272.20%
Q3 2022-18.50%
Q2 20220.00%